Rosie O’Donnell shared how she feels about her recent dramatic weight loss in a May 23 Instagram post alongside a photo of her slimmer body.

a biweekly injection of antibodies that sop up the enzyme called PCSK9, which strongly effects blood levels of LDL. Amgen followed just weeks later, with the PCSK9 antibody Repatha. In 2021 ...

The rapid addition of small interfering RNA therapy to usual care after a recent ACS helps more patients achieve recommended ...

Evolocumab (Repatha) dramatically lowers LDL cholesterol ... In that study, the only significant side effect was injection-site reaction. Scientists have since analyzed data from this study ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

and Sanofi/Regeneron’s Repatha (alirocumab) – but these require subcutaneous injection every two to four weeks. Sales of both the commercially available antibodies have failed to live up to ...

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of ...

Forty years after the first statin drug started lowering levels of artery-choking cholesterol, heart attacks and strokes remain the world’s biggest killers. This year will see test results on some ...